Impaired baroreflex function and arterial compliance in primary aldosteronism

Journal of Human Hypertension

Volumn 13, Issue 1, 1999, Pages 29-36

  Veglio, Franco ^a   Molino, P ^b   Cat Genova, G ^b   Melchio, R ^b   Rabbia, F ^b   Grosso, T ^b   Martini, G ^b   Chiandussi, L ^b  

^a Ospedale San Vito   (Italy)

^b NONE

Author keywords

Baroreflex; Compliance; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; SPIRONOLACTONE;

ADULT; AGE; ALDOSTERONE BLOOD LEVEL; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIASTOLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FINGER BLOOD FLOW; GYNECOMASTIA; HUMAN; MALE; MEDICAL INSTRUMENTATION; PRESSORECEPTOR REFLEX; PRIMARY HYPERALDOSTERONISM; REST; SEXUAL DYSFUNCTION; SPECTROSCOPY; STANDING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

EID: 0032945767     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000737     Document Type: Article

References (40)

1. Lage SG, Polak JF, O'Leary DH, Creager MA. Relationship of arterial compliance to baroreflex function in hypertensive patients. Am J Physiol 1993; 265: H232-H237.
2. Biglieri EG, Mcllroy MB. Abnormalities of renal function and circulatory reflexes in primary aldosteronism. Circulation 1966; 33: 78-86.
3. Veglio F et al. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism. Am J Hypertens 1995; 8: 479-486.
4. Robert V et al. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994; 24: 30-36.
5. Weber KT et al. Vascular remodelling and mineral-ocorticoids. J Endocrinol Invest 1995; 18: 533-539.
6. Rizzoni D et al. Structural changes of small resistance arteries in patients with secondary hypertension. Seventh European Meeting on Hypertension, Milan, 1995; 159 (Abstract).
7. Robbe HWJ et al. Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 1987; 10: 538-543.
8. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension 1995; 25: 1276-1286.
9. Shim Y et al. Arterial Windkessel parameter estimation: a new time domain method. Ann Biomed Engineering 1994; 22; 66-77.
10. Finkelstein SM, Cohn JN. First and third-order models determining arterial compliance. J Hypertens 1992; 10: S11-S14.
11. William FWJ, Klee GG. Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988; 17: 367-395.
12. Imholz BPM et al. Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. Hypertension 1993; 21: 65-73.
13. Penaz J. Photoelectric measurement of blood pressure, volume and flow in the finger. Digest 10th Int Conf Med Bio Engen, Dresden 1973, p 104.
14. Cohn JN et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995; 26: 503-508.
15. Messerli FH, Frohlich ED, Ventura HO. Arterial compliance in essential hypertension. J Cardiovasc Pharmacol 1985; 7: S33-S35.
16. Ventura H et al. Impaired systemic arterial compliance in borderline hypertension. Am Heart J 1984; 108: 132-136.
17. Simon A, Levenson J. Use of arterial compliance for evaluation of hypertension. Am J Hypertens 1990; 3: 97-105.
18. Williams ED et al. Body elemental composition, with particular reference to total and exchangeable sodium and potassium and total chlorine, in untreated and treated primary aldosteronism. J Hypertens 1984; 2: 171-176.
19. Wenting GJ, Man in't Veld AJ, Derkx FHM, Schalekamp MADH. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes. Clin Exp Hypertens [A] 1982; 4: 1727-1748.
20. Wang W, McCain J, Zucker I. Aldosterone reduces baroreceptor discharge in the dog. Hypertension 1992; 19: 270-276.
21. Wang W. Chronic administration of aldosterone depress baroreceptor reflex function in the dog. Hypertension 1994; 24: 571-575.
22. Butler GC, Senn BL, Floras JS. Influence of Atrial Natriuretic: Factor on spontaneous baroreflex sensitivity for heart rate in humans. Hypertension 1995; 25: 1167-1171.
23. Veelken R et al. Impaired cardiovascular reflexes precede deoxyorticosterone acetate-salt hypertension. Hypertension 1994; 24: 564-570.
24. Chapleau MW et al. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995; 26: 341-347.
25. Munakata M et al. Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism. J Hypertens 1995; 13: 1648-1653.
26. Herpin D, Ragot S. Mid-and long-term reproducibility of noninvasive measurements of spontaneous arterial baroreflex sensitivity in healthy volunteers. Am J Hypertens 1997; 10: 790-797.
27. Watkins LL, Grossman P, Sherwood A. Noninvasive assessment of baroreflex control in borderline hypertension. Hypertension 1996; 28: 238-243.
28. Castellano M et al. Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxyde synthesis inhibition in humans. J Hypertens 1995; 13: 1153-1161.
29. Munakata M et al. Decreased blood pressure variability at rest in patients with primary aldosteronism. Am J Hypertens 1998; 11: 828-838.
30. Neutel JM, Smith DHG, Graettinger WF, Weber MA. Dependency of arterial compliance on circulating neuroendocrine factors and metabolic factors in normal subjects. Am J Cardiol 1992; 69: 1340-1344.
31. Brilla CG, Zhou G, Masubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26: 809-820.
32. Grassi G et al. Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 1995; 26: 348-354.
33. Raab W, Humpreys RJ, Lepeschkin E. Potentiation of pressor effects of norepinephrine and epinephrine in man by desoxycorticosterone acetate. J Clin Invest 1950; 29: 1397-1401.
34. Friedman SM. Additive effects of aldosterone with vasopressin or angiotensin. Hypertension 1984; 6: 242-248.
35. Bravo E, Tarazi R, Dustan H, Fouad F. The sympathetic nervous system and hypertension in primary aldosteronism. Hypertension 1985; 7: 90-96.
36. Miyajima E et al. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991; 17: 1057-1062.
37. Parlow J et al. Spontaneous cardiac baroreflex in humans. Comparison with drug induced responses. Hypertension 1995; 25: 1058-1068.
38. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
39. Omboni S et al. Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intraarterial recordings. Hypertension 1993; 22: 26-33.
40. Parati G et al. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 13: 647-655.